Clinicopathologic factors | Number of patients (%) |
---|---|
Histologic type | |
Serous | 140 (56.5) |
Mucinous | 47 (19.0) |
Endometrioid | 19 (7.7) |
Clear | 42 (16.9) |
Residual tumor | |
Optimal | 167 (90.8) |
Suboptimal | 17 (9.2) |
Tumor grade | |
1 | 57 (23.0) |
2 | 122 (49.2) |
3 | 69 (27.8) |
Tumor stage | |
Early | 68 (37.2) |
Advanced | 115 (62.8) |
Nuclear grade | |
Mild and moderate | 137 (55.2) |
Marked | 111 (44.8) |
Mitosis | |
0–9/10 HPFs | 93 (37.5) |
10–24/10 HPFs | 95 (38.3) |
> =25/10 HPFs | 60 (24.2) |
Chemoresponse | |
Regressive disease | 73 (43.5) |
Stable/progressive disease | 95 (56.5) |